Health Care & Life Sciences » Biotechnology | Aratana Therapeutics Inc.

Aratana Therapeutics Inc.

Aratana Therapeutics Inc.
Stock Exchange Frankfurt Stock Exchange
EPS
-
Market Cap
-
Shares Outstanding
47.67 M
Public Float
39.61 M
Aratana Therapeutics Inc.
Stock Exchange NASDAQ Stock Market
EPS
$0.27
Market Cap
$252.86 M
Shares Outstanding
49 M
Public Float
46.65 M

Profile

Address
11400 Tomahawk Creek Parkway
Leawood Kansas 66211
United States
Employees -
Website http://www.aratana.com
Updated 07/08/2019
Aratana Therapeutics, Inc. operates as a development stage biopharmaceutical company, which focuses on the licensing, development and commercialization of innovative prescription medications for pets or pet therapeutics. It delivers prescription medicines that address significant medical needs for cats and dogs. The firm licenses proprietary, patent-protected compounds from human pharmaceutical and biotechnology companies.

Financials

View All

Wendy L. Yarno
Non-Executive Chairman
Steven St. Peter
President, Chief Executive Officer & Director